Christine Sacco - May 24, 2023 Form 4 Insider Report for Prestige Consumer Healthcare Inc. (PBH)

Role
Chief Financial Officer
Signature
/s/ Christine Sacco by William P'Pool as attorney-in-fact pursuant to power of attorney dated May 8, 2017 on file with the Commission
Stock symbol
PBH
Transactions as of
May 24, 2023
Transactions value $
-$1,468,319
Form type
4
Date filed
5/26/2023, 04:04 PM
Previous filing
May 8, 2023
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBH Common Stock, par value $0.01 per share Options Exercise $633K +11.3K +24.94% $56.11 56.5K May 24, 2023 Direct
transaction PBH Common Stock, par value $0.01 per share Sale -$678K -11.3K -19.96% $60.07 45.2K May 24, 2023 Direct F1
transaction PBH Common Stock, par value $0.01 per share Options Exercise $1.22M +25.7K +56.92% $47.39 71K May 24, 2023 Direct
transaction PBH Common Stock, par value $0.01 per share Sale -$1.55M -25.7K -36.27% $60.07 45.2K May 24, 2023 Direct F1
transaction PBH Common Stock, par value $0.01 per share Sale -$1.1M -18.3K -40.38% $60.07 27K May 24, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBH Employee Stock Options (rights to buy) Options Exercise $0 -11.3K -100% $0.00* 0 May 24, 2023 Common Stock 11.3K $56.11 Direct F2
transaction PBH Employee Stock Options (rights to buy) Options Exercise $0 -25.7K -100% $0.00* 0 May 24, 2023 Common Stock 25.7K $47.39 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $59.00 to $60.07.
F2 Options vested and became exercisable on the third anniversary of the grant date.